Join Our Newsletter

Innate Immunotherapeutics Ltd - INNMF

RSI %R Tweets Wolf Odds
54 0 1 30.61%

Industry: Biotechnology / Sector: Healthcare



Prev Close: 0.01968
Open: 0.0200
Last Trade: 0.03
Change %: +52.440%
Change: +0.0103200
Volume: 231178
Avg Vol: 89345
Relative Vol: 2.59
Day Range: 0.02 -0.03
52-Week Range: 0.0150 - 1.6000
Market Cap: 4.96M
Float: 153.8M
Shares Outstanding: N/A
Insider Owned: 0.00%
Institution Owned: 0.00%
Beta: 0.00
PE Ratio: 0.00
EPS: -0.021

INNMF Detailed Stats

RSI:53.54 %K:100.00 Wolf Odds: 30.61% Tweets Today:1 SMA14:0.0192
stochRSI:0.59 %D:64.24 Wolf Trend:0.27 Tweet Avg:1 Pivot Price:0.0266667
%R:0.00 %B:1.32 Wolf 3-Day:0.49 Avg. Change 3-Day:+21.313% Resistance 1:0.0333333
MFI:77.23 Bandwidth:0.692114 Wolf 7-Day:0.27 Avg. Change 7-Day:+8.199% Resistance 2:0.0366667
WolfPeak:0.62 Vortex Indicator:0.24 Wolf 14-Day:0.25 Avg. Change 14-Day:+4.41% Support 1:0.0233333
ROC 7/14:57.8947/50.0000 Aroon Oscillator:42.8571 EOM:0.001153 Relative Vol:2.59 Support 2:0.0166667
RSI Alert:None WolfPeak Alert:None Vortex Alert:None Aroon Alert:None EOM Alert:Positive Cross

Featured News *


INNMF Description

Innate Immunotherapeutics Limited, a medical biotechnology company, researches, develops, manufactures, and sells drugs in Australia and New Zealand. The company offers a unique immunomodulator microparticle technology that is used to induce the human immune system to fight various cancers and infections, or modulate various immune mechanisms implicated in autoimmune diseases, such as multiple sclerosis, as well as for the design of vaccines to treat or prevent diseases, including influenza, cancer, malaria, or tuberculosis. Its lead drug candidate is MIS416 that is in Phase IIB clinical trial to treat patients with secondary progressive multiple sclerosis. The company was formerly known as Innate Therapeutics Limited and changed its name to Innate Immunotherapeutics Limited in August 2009. Innate Immunotherapeutics Limited was incorporated in 2000 and is based in Sydney, Australia.

INNMF Comments

Recent INNMF Tweets

Powered by Ekonomys ver. 9

StockWolf is dedicated to Penny Stock quotes and data to provide information, news, and education on penny stocks to help in your due diligence.

30min+ delay on data. All data is picked with automated algorithms and not vetted for accuracy. Please, read ALL information and disclaimers before using our service. StockWolf is not a licensed financial adviser, and not liable for your loses. Trade responsibly. This site is for education purposes only not a recommendation to buy/sell